In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
The efficacy of rifabutin (RIFA) alone or in combination with atovaquone (ATO) was examined in vitro and in a murine model of acute toxoplasmosis. In vitro studies were performed with MRC5 fibroblast tissue cultures, with quantification of Toxoplasma growth by enzyme-linked immunosorbent assay. For...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1996
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8878573/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.9.2015 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|